Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$824M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$459M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
| 4 |
Warner Bros
WBD
|
+$287M |
| 5 |
Tesla
TSLA
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.88B |
| 2 |
AT&T
T
|
+$530M |
| 3 |
Meta Platforms (Facebook)
META
|
+$481M |
| 4 |
Workday
WDAY
|
+$462M |
| 5 |
Apple
AAPL
|
+$354M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.22% |
| 2 | Technology | 1.79% |
| 3 | Consumer Discretionary | 1.52% |
| 4 | Communication Services | 1.04% |
| 5 | Financials | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLAI
11776
PUT
DELISTED
SOLAI Ltd ADS
SLAI
| $61K | ﹤0.01% |
1,403
-354
| -20% | -$44.3K |
|
11777
Curis
CRIS
$3.69M
| $61K | ﹤0.01% |
156
-243
| -61% | -$101K |
|
11778
DB Gold Double Short ETN due Feb 15 2038
DZZ
$2.97M
| $61K | ﹤0.01% |
22,348
+4,662
| +26% | +$11.8K |
|
11779
PUT
Owlet
OWLT
$144M
| $61K | ﹤0.01% |
2,550
+1,700
| +200% | +$84.1K |
|
11780
PUT
Porch Group
PRCH
$2B
| $61K | ﹤0.01% |
23,800
+12,200
| +105% | +$50.5K |
|
11781
PUT
Pixelworks
PXLW
$42.5M
| $61K | ﹤0.01% |
2,658
-13,675
| -84% | -$354K |
|
|
ZH
11782
PUT
Zhihu
ZH
$257M
| $61K | ﹤0.01% |
5,533
-2,884
| -34% | -$31K |
|
|
PCTI
11783
CALL
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $61K | ﹤0.01% |
14,900
-8,100
| -35% | -$34.3K |
|
11784
CALL
AC Immune
ACIU
$267M
| $60K | ﹤0.01% |
16,500
-84,100
| -84% | -$288K |
|
|
11785
AC Immune
ACIU
$267M
| $60K | ﹤0.01% |
16,546
-9,562
| -37% | -$32.7K |
|
|
BRAG
11786
CALL
Bragg Gaming Group
BRAG
$44.7M
| $60K | ﹤0.01% |
13,300
-13,700
| -51% | -$73.4K |
|
|
BRFS
11787
CALL
DELISTED
BRF SA
BRFS
| $60K | ﹤0.01% |
23,600
+8,900
| +61% | +$26.3K |
|
|
CISO
11788
PUT
CISO Global
CISO
$10.2M
| $60K | ﹤0.01% |
+1,107
| New | +$85.9K |
|
11789
CALL
Cumberland Pharmaceuticals
CPIX
$134M
| $60K | ﹤0.01% |
28,900
-3,900
| -12% | -$9.02K |
|
11790
CALL
Ensysce Biosciences
ENSC
$7.64M
| $60K | ﹤0.01% |
19
-6
| -24% | -$16.8K |
|
|
MARK
11791
CALL
DELISTED
Remark Holdings, Inc.
MARK
| $60K | ﹤0.01% |
13,720
+4,750
| +53% | +$25.3K |
|
|
RVLP
11792
CALL
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $60K | ﹤0.01% |
44,000
-3,100
| -7% | -$4.49K |
|
|
ENDP
11793
PUT
DELISTED
Endo International plc
ENDP
| $60K | ﹤0.01% |
128,500
-55,000
| -30% | -$69.9K |
|
11794
Abits Group
ABTS
$4.34M
| $59K | ﹤0.01% |
3,947
+854
| +28% | +$16.8K |
|
11795
KULR Technology Group
KULR
$123M
| $59K | ﹤0.01% |
4,755
-6,906
| -59% | -$92.2K |
|
11796
PUT
Milestone Pharmaceuticals
MIST
$143M
| $59K | ﹤0.01% |
+10,000
| New | +$61.4K |
|
11797
CALL
Neurogene
NGNE
$734M
| $59K | ﹤0.01% |
2,870
-1,550
| -35% | -$37.8K |
|
11798
XWELL
XWEL
$8.42M
| $59K | ﹤0.01% |
4,296
-10,215
| -70% | -$180K |
|
|
LENZ
11799
CALL
LENZ Therapeutics
LENZ
$149M
| $59K | ﹤0.01% |
+3,086
| New | +$68.8K |
|
|
GENE
11800
DELISTED
Genetic Technologies Ltd.
GENE
| $59K | ﹤0.01% |
10,341
+3,762
| +57% | +$27.2K |
|
Similar funds
Jeff Yass's Q2 2022 Portfolio in Review
As of Q2 2022, Jeff Yass held 14,668 positions worth $404B, down 30% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q2 2022 filing shows 1,801 new, 4,898 increased, 5,771 reduced and 1,897 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.88B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2022 buy was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M.
- Jeff Yass added most to Amazon in Q2 2022, an estimated $824M increase.
- Jeff Yass's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.88B.
- Jeff Yass fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $176M.
- Jeff Yass's ten largest holdings make up 32% of its $404B portfolio in Q2 2022.
- Jeff Yass opened 1,801 new positions and closed 1,897 in Q2 2022.
- Jeff Yass's portfolio value fell 30% quarter-over-quarter to $404B.
Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.